Explore. Inspire
Reports 9 Aug 2022

Gone with the Pandemic: The ABC of restoring business health and confidence

The pandemic not only claimed the lives of loved ones, healthcare workers and thousands of people unable to get a vaccine or adequate medical care, it also wiped out thousands of jobs, generating an unprecedented economic crisis that served to prove just how essential health and wellness are for the global economy.

COVID-19 elicited catastrophic evidence of how ill-prepared governments and their health systems are to deal with health emergencies, and also the lack of support for health professionals who lack the equipment, hospital infrastructure, clinical supplies and in some cases medicines to help their patients.

The pandemic’s most tenacious impact  has been felt by patients whose health has deteriorated over the course of two years, as they have been left without medical services, medication, complete vaccination schedules and support services, not to mention the basic necessities to maintain their level of health and quality of life.

Before 2020, governments had failed to prioritize global healthcare until it was too late; and the results have been disastrous. Governments were unprepared for a pandemic of this magnitude, as they had reduced investment in healthcare and failed to bolster their healthcare systems.

The pandemic posed challenges for all actors in the health sector, governments, the medical community, and pharmaceutical, device and health technology companies. The latter, a sector highly criticised for a lack of transparency and responsiveness in demonstrating the value of research and development of molecules and technologies that help minimise the impact of diseases and contribute to a healthier and more productive society.

We will review here the impact of the pandemic on service delivery and the provision of healthcare supplies and analyse current needs and possible solutions for how governments and businesses can work together to restore confidence and, more importantly, make up for lost years in terms of public health and wellness.

<!--[if lte IE 8]>
<![endif]-->DOWNLOAD
hbspt.cta.load(2673737, '0bb36f60-1e40-46e2-8c1d-ad47120d4420', {"useNewLoader":"true","region":"na1"});
Alejandro Romero
Partner and CEO Americas
Since 1998 he has been at the forefront of the company's expansion process in the in the Americas, initiating operations in Peru, Argentina, Colombia, Panama, Panama, Ecuador, Mexico, Colombia, Panama, Ecuador, Mexico and as of the last four years,Miami. Alejandro has also headed the communication processes of three of the ten most important M&A transactions in the region: the sale of BellSouth's operations to the Telefonica Group, the acquisition by SABMiller of Grupo Empresarial Bavaria and the sale of Grupo Financiero Uno to Citibank. In 20 years, he has positioned our firm as the leading communications network in Latin America.
Georgina Rosell
Senior Director at LLYC Barcelona
More than 15 years advising the pharmaceutical industry in its cultural transformation, reputation and innovation challenges, including for seven out of the ten main companies in the pharmaceutical industry in the MERCO 2020 Health Reputation Monitor. Daughter of a doctor and a pharmacist, Gina Rosell is also an expert in the socio-health, hospital, care home and medical/scientific sector, a field in which she has a great relational capacity at an institutional level and with the third sector.Her training as a political scientist specialized in international relations, with a Master’s degree in Communication and Sustainability Management offers her a broad-based focus in her organizational challenges with results that have been internationally recognized for their impact, sensitivity and creativity.Georgina has been with the firm for more than ten years, is a Senior Director and heads up the Health Communication Department at a European level.
Javier Marín
Senior Director Healthcare Americas
Javier Marin is a communications and public affairs professional with vast experience in the public and private sectors, having worked with pharmaceutical, biotech and life sciences companies for over 20 years. Throughout his career, he has developed social campaigns for disease prevention and health care for the Mexican government. He has also carried out corporate communications, government affairs, internal communications, marketing, digital and social corporate responsibility efforts, as well as led programs for patient associations on the local, Latin American and global levels, working with companies such as Merck & Co. (MSD) and Johnson & Johnson.
Ana Lluch
Senior Healthcare Consultant at LLYC Americas.
Ana is a journalism graduate specialized in corporate communications with well over 7 years of experience in the consulting industry, working with international clients in Spain, the United States and Latin America. She has worked in companies such as BBVA, Cohn & Wolfe and ATREVIA. At LLYC, she specializes in content creation and narrative development for multinational healthcare companies and in the regional coordination of multicountry projects for pharmaceutical or medical device companies in the Americas. Just a few of the many clients with whom she has collaborated: Astellas, AbbVie, Bayer, Roche, CureVac, Medtronic, etc.
Alejandro González Mondragón
 Senior Consultant
Alejandro has 10 years of experience in the areas of public affairs, advocacy, access and communication for the pharmaceutical industry. Throughout his career, he has designed and implemented strategies for companies such as AstraZeneca, Biogen, Janssen, Merck, MSD, Pfizer and Roche specializing in the challenges of access and availability of innovative medicines, especially advanced therapies for rare diseases and oncology.
Do you want to know more about it?
Areas
    Professionals

      We want to collaborate with you

      Do you have a challenge?

      Would you like to join our team?

      Do you want us to speak at your next event?